D430-0371 Screening compound: N-(4-{[2-methyl-6-(pyrrolidin-1-yl)pyrimidin-4-yl]amino}phenyl)-2-oxo-2H-chromene-3-carboxamide

D430-0371 Screening compound: N-(4-{[2-methyl-6-(pyrrolidin-1-yl)pyrimidin-4-yl]amino}phenyl)-2-oxo-2H-chromene-3-carboxamide
D430-0371 Screening compound: N-(4-{[2-methyl-6-(pyrrolidin-1-yl)pyrimidin-4-yl]amino}phenyl)-2-oxo-2H-chromene-3-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound D430-0371
N-(4-{[2-methyl-6-(pyrrolidin-1-yl)pyrimidin-4-yl]amino}phenyl)-2-oxo-2H-chromene-3-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

D430-0371

Molecular Formula

C25H23N5O3 (C25 H23 N5 O3)

Compound Name

N-(4-{[2-methyl-6-(pyrrolidin-1-yl)pyrimidin-4-yl]amino}phenyl)-2-oxo-2H-chromene-3-carboxamide

IUPAC name

N-(4-{[2-methyl-6-(pyrrolidin-1-yl)pyrimidin-4-yl]amino}phenyl)-2-oxo-2H-chromene-3-carboxamide

SMILES

Cc1nc(N2CCCC2)cc(Nc(cc2)ccc2NC(C2=Cc(cccc3)c3OC2=O)=O)n1

InChI

InChI=1S/C25H23N5O3/c1-16-26-22(15-23(27-16)30-12-4-5-13-30)28-18-8-10-19(11-9-18)29-24(31)20-14-17-6-2-3-7-21(17)33-25(20)32/h2-3,6-11,14-15H,4-5,12-13H2,1H3,(H,29,31)(H,26,27,28)

InChI Key

UKXCQXDCWVKDIS-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14828417

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

441.49

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.466

Distribution Coefficient, logD

4.180

Water Solubility, LogSw

-4.40

Polar Surface Area

75.197

Acid Dissociation Constant (pKa)

10.01

Base Dissociation Constant (pKb)

7.37

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

20.00

D430-0371 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Aurora A-B Kinases Targeted Library (9426 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Male
  • Female
  • Hemic and lymphatic
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with D430-0371 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound D430-0371?
Check Price and Availability of D430-0371, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of D430-0371 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for D430-0371
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for D430-0371
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of D430-0371 available by request